Conferences
ASCO
Rapid Reactions
Breast Cancer
GI Cancer
GU Cancer
Head and Neck Cancer
Hematology
Lung Cancer
ASCO GI
Biliary/Liver Cancer
Colorectal Cancer
Gastric/GEJ Cancer
General GI Cancer
Pancreatic Cancer
ASCO GU
Bladder Cancer
General GU Oncology
Prostate Cancer
RCC
ASH
General Hematology
Leukemia
Lymphoma
Multiple Myeloma
EHA
ESMO
Breast Cancer
GI Oncology
GU Oncology
Lung Cancer
SABCS
General Breast Cancer
HER2-Positive Breast Cancer
HR+ Disease
TNBC
WCLC
Videos & Podcasts
Challenging Cases
Breast Cancer
GU Oncology
Hematology
Lung Cancer
New Approvals
Breast Cancer
GI Oncology
GU Oncology
Hematology
Lung Cancer
Tox Check
Breast Cancer
GI Oncology
GU Oncology
Hematology
Lung Cancer
Treatment Algorithms
Breast Cancer
Dermatology
GI Oncology
GU Cancer
Head and Neck Cancers
Hematology
Lung Cancer
Ovarian Cancer
Clinical Insights
Breast Cancer
Early HR+
Metastatic HR+
GI Oncology
Gastric/GEJ Cancer
Pancreatic Cancer
GU Oncology
Bladder Cancer
RCC
Head & neck cancers
Hematology
Leukemia
MDS
Multiple Myeloma
Polycythemia Vera
Lung Cancer
NSCLC
SCLC
Resource Centers
Cell Therapy
Metastatic Breast Cancer
Pancreatic Cancer
Articles
Breast Cancer
General News
GI Oncology
GU Oncology
Hematology
Lung Cancer
Events
Subscribe
Conferences
ASCO
Rapid Reactions
Breast Cancer
GI Cancer
GU Cancer
Head and Neck Cancer
Hematology
Lung Cancer
ASCO GI
Biliary/Liver Cancer
Colorectal Cancer
Gastric/GEJ Cancer
General GI Cancer
Pancreatic Cancer
ASCO GU
Bladder Cancer
General GU Oncology
Prostate Cancer
RCC
ASH
General Hematology
Leukemia
Lymphoma
Multiple Myeloma
EHA
ESMO
Breast Cancer
GI Oncology
GU Oncology
Lung Cancer
SABCS
General Breast Cancer
HER2-Positive Breast Cancer
HR+ Disease
TNBC
WCLC
Videos & Podcasts
Challenging Cases
Breast Cancer
GU Oncology
Hematology
Lung Cancer
New Approvals
Breast Cancer
GI Oncology
GU Oncology
Hematology
Lung Cancer
Tox Check
Breast Cancer
GI Oncology
GU Oncology
Hematology
Lung Cancer
Treatment Algorithms
Breast Cancer
Dermatology
GI Oncology
GU Cancer
Head and Neck Cancers
Hematology
Lung Cancer
Ovarian Cancer
Clinical Insights
Breast Cancer
Early HR+
Metastatic HR+
GI Oncology
Gastric/GEJ Cancer
Pancreatic Cancer
GU Oncology
Bladder Cancer
RCC
Head & neck cancers
Hematology
Leukemia
MDS
Multiple Myeloma
Polycythemia Vera
Lung Cancer
NSCLC
SCLC
Resource Centers
Cell Therapy
Metastatic Breast Cancer
Pancreatic Cancer
Articles
Breast Cancer
General News
GI Oncology
GU Oncology
Hematology
Lung Cancer
Events
Subscribe
TTLC 2026
Home
/
Clinical Insights
/
Lung Cancer
/
NSCLC
/
TTLC 2026
Interview
View All
Interview
03/15/2026
Ep. 3: Intensification Strategies and CNS Management in EGFR-Mutant NSCLC
Chinmay Jani, MD
Luis Raez, MD, FACP, FCCP, FASCO
Interview
03/13/2026
Ep. 2: Subcutaneous Amivantamab Reshapes Frontline EGFR-Mutant NSCLC Care
Chinmay Jani, MD
Luis Raez, MD, FACP, FCCP, FASCO
Interview
03/11/2026
Ep. 1: Overcoming Infusion Barriers in EGFR-Mutant Non–Small Cell Lung Cancer
Chinmay Jani, MD
Luis Raez, MD, FACP, FCCP, FASCO
Roundtable
View All
Roundtable
03/19/2026
Ep. 3: Time Toxicity, CNS Risk, and Sequencing Strategy in EGFR-Mutant NSCLC
Eric Singhi, MD
Sarah Goldberg, MD, MPH
Fawzi Abu Rous, MD
Julia Rotow, MD
Susan Scott, MD
Roundtable
03/17/2026
Ep. 2: Clinical Insights: Proactive Toxicity Management and CNS Control in EGFR-Mutant NSCLC
Eric Singhi, MD
Sarah Goldberg, MD, MPH
Susan Scott, MD
Fawzi Abu Rous, MD
Julia Rotow, MD
Roundtable
03/14/2026
Ep. 1: OS Benefit and Patient-Centered Delivery Advances in EGFR-Mutant NSCLC
Eric Singhi, MD
Susan Scott, MD
Sarah Goldberg, MD, MPH
Fawzi Abu Rous, MD
Julia Rotow, MD